Blood Coagulation Factors
"Blood Coagulation Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous substances, usually proteins, that are involved in the blood coagulation process.
| Descriptor ID |
D001779
|
| MeSH Number(s) |
D12.776.124.125 D23.119
|
| Concept/Terms |
Blood Coagulation Factors- Blood Coagulation Factors
- Blood Coagulation Factor
- Factor, Blood Coagulation
- Coagulation Factor, Blood
- Coagulation Factors, Blood
- Factors, Blood Coagulation
- Coagulation Factors
- Factor, Coagulation
- Factors, Coagulation
- Coagulation Factor
- Clotting Factors
- Factors, Clotting
|
Below are MeSH descriptors whose meaning is more general than "Blood Coagulation Factors".
Below are MeSH descriptors whose meaning is more specific than "Blood Coagulation Factors".
This graph shows the total number of publications written about "Blood Coagulation Factors" by people in this website by year, and whether "Blood Coagulation Factors" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1997 | 1 | 1 | 2 |
| 1998 | 4 | 0 | 4 |
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 5 | 1 | 6 |
| 2002 | 3 | 0 | 3 |
| 2003 | 5 | 0 | 5 |
| 2004 | 3 | 4 | 7 |
| 2005 | 3 | 3 | 6 |
| 2006 | 1 | 3 | 4 |
| 2007 | 5 | 2 | 7 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 2 | 3 |
| 2011 | 2 | 2 | 4 |
| 2012 | 5 | 2 | 7 |
| 2013 | 5 | 1 | 6 |
| 2014 | 4 | 2 | 6 |
| 2015 | 5 | 0 | 5 |
| 2016 | 3 | 2 | 5 |
| 2017 | 7 | 2 | 9 |
| 2018 | 4 | 1 | 5 |
| 2019 | 2 | 3 | 5 |
| 2020 | 4 | 3 | 7 |
| 2021 | 3 | 2 | 5 |
| 2022 | 1 | 6 | 7 |
| 2023 | 0 | 2 | 2 |
| 2024 | 3 | 2 | 5 |
Below are the most recent publications written about "Blood Coagulation Factors" by people in Profiles.
-
4-Factor prothrombin complex concentrates and factor VIII inhibitor bypass activity use in cardiac surgery. Blood Coagul Fibrinolysis. 2025 Jan 01; 36(1):18-25.
-
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood. 2024 05 30; 143(22):2256-2269.
-
Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter study. J Trauma Acute Care Surg. 2024 Oct 01; 97(4):541-545.
-
Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studies. Brain Behav Immun. 2024 Jul; 119:188-196.
-
The Effect of 4-Factor Prothrombin Complex Concentrate to Reverse Factor Xa Inhibitors in Patients With Traumatic Intracranial Hemorrhage. Am Surg. 2024 Jul; 90(7):1904-1906.
-
Cellular stress and coagulation factor production: when more is not necessarily better. J Thromb Haemost. 2023 12; 21(12):3329-3341.
-
Platelet factors are induced by longevity factor klotho and enhance cognition in young and aging mice. Nat Aging. 2023 09; 3(9):1067-1078.
-
Coagulation factor with potential for the treatment of heart failure. Clin Transl Med. 2022 12; 12(12):e1144.
-
Comprehensive analysis of coagulation factor delivery strategies in a cohort of trauma patients. Anaesth Crit Care Pain Med. 2023 04; 42(2):101180.
-
Safety of FEIBA and emicizumab (SAFE): Dose escalation study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemophilia A patients on emicizumab. Haemophilia. 2023 Jan; 29(1):100-105.